Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial results for quetiapine fumarate (SEROQUEL) in adolescent patients with schizophrenia and Bipolar I Disorder. The study has completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-10-05